Azimi lab publications

Selected highlight publications

1. Maklad A, Sedeeq M, Wilson R, Heath JA, Gueven N, Azimi I*. LIN28 expression and function in medulloblastoma. Journal of Cellular Physiology. 2023;238(3):533-548.

2. Sedeeq M, Maklad A, Dutta T, Feng Z, Wilson R, Gueven N, Azimi I*. T-Type Calcium Channel Inhibitors Induce Apoptosis in Medulloblastoma Cells Associated with Altered Metabolic Activity. Molecular Neurobiology. 2022;59(5):2932-2945.

3. Maklad A, Sedeeq M, Milevskiy MJG, Azimi I*. Calcium Signalling in Medulloblastoma: An In Silico Analysis of the Expression of Calcium Regulating Genes in Patient Samples. Genes. 2021;12(9):1329.

4. Sedeeq M, Maklad A, Gueven N, Azimi I*. Development of a High-throughput Agar Colony Formation Assay to Identify Drug Candidates against Medulloblastoma. Pharmaceuticals. 2020;13(11):368.

5. Mohammadinejad R, Biagioni A, Arunkumar G, Shapiro R, Chang KC, Sedeeq M, Taiyab A, Hashemabadi M, Pardakhty A, Mandegary A, Thiery JP, Aref AR, Azimi I*. EMT signaling: potential contribution of CRISPR/Cas gene editing. Cellular and Molecular Life Sciences. 2020;77(14):2701-2722.

6. Azimi I*, Petersen RM, Thompson EW, Roberts-Thomson SJ, Monteith GR. Hypoxia-induced reactive oxygen species mediate N-cadherin and SERPINE1 expression, EGFR signalling and motility in MDA-MB-468 breast cancer cells. Scientific Reports. 2017;7(1):15140.

7. Azimi I, Stevenson RJ, Zhang X, Meizoso-Huesca A, Xin P, Johnson M, Flanagan JU, Chalmers SB, Yoast RE, Kapure JS, Ross BP, Vetter I, Ashton MR, Launikonis BS, Denny WA, Trebak M, Monteith GR. A new selective pharmacological enhancer of the Orai1 Ca2+ channel reveals roles for Orai1 in smooth and skeletal muscle functions. ACS Pharmacology & Translational Science. 2020;3(1):135-147.

*Corresponding author.

Additional publications

A full list of Azimi Lab publications can be viewed on Google Scholar.